Detalhe da pesquisa
1.
COVID-19 immune signatures reveal stable antiviral T cell function despite declining humoral responses.
Immunity
; 54(2): 340-354.e6, 2021 02 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33567252
2.
A Phase 3, Randomized Trial of Bulevirtide in Chronic Hepatitis D.
N Engl J Med
; 389(1): 22-32, 2023 Jul 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37345876
3.
HBV DNA and HBsAg Levels at 24 Weeks Off-Treatment Predict Clinical Relapse and HBsAg Loss in HBeAg-Negative Patients Who Discontinued Antiviral Therapy.
Gastroenterology
; 166(1): 168-177.e8, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37769952
4.
Impending HCC diagnosis in patients with cirrhosis after HCV cure features a natural killer cell signature.
Hepatology
; 2024 Feb 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38381525
5.
Validation of Baveno VII criteria and other non-invasive diagnostic algorithms for clinically significant portal hypertension in hepatitis delta.
J Hepatol
; 2024 Mar 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38479612
6.
Bulevirtide monotherapy in patients with chronic HDV: Efficacy and safety results through week 96 from a phase 3 randomized trial.
J Hepatol
; 2024 May 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38734383
7.
Proteomics reveals a global phenotypic shift of NK cells in HCV patients treated with direct-acting antivirals.
Eur J Immunol
; 53(11): e2250291, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37515498
8.
Limited Sustained Remission After Nucleos(t)ide Analog Withdrawal: Results From a Large, Global, Multiethnic Cohort of Patients With Chronic Hepatitis B (RETRACT-B Study).
Am J Gastroenterol
; 2024 Apr 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38483300
9.
Elevation of S2-bound α1-acid glycoprotein is associated with chronic hepatitis C virus infection and hepatocellular carcinoma.
J Viral Hepat
; 2024 Apr 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38610115
10.
Emergence of resistance-associated variants during sofosbuvir treatment in chronically infected hepatitis E patients.
Hepatology
; 78(6): 1882-1895, 2023 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37334496
11.
Five-year follow-up of 96 weeks peginterferon plus tenofovir disoproxil fumarate in hepatitis D.
Liver Int
; 44(1): 139-147, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37787009
12.
Experience and impact of stigma in people with chronic hepatitis B: a qualitative study in Asia, Europe, and the United States.
BMC Public Health
; 24(1): 611, 2024 Feb 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38408941
13.
Reverse inflammaging: Long-term effects of HCV cure on biological age.
J Hepatol
; 78(1): 90-98, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36152762
14.
A multicenter randomized-controlled trial of nucleos(t)ide analogue cessation in HBeAg-negative chronic hepatitis B.
J Hepatol
; 78(5): 926-936, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37062574
15.
Differential Relapse Patterns After Discontinuation of Entecavir vs Tenofovir Disoproxil Fumarate in Chronic Hepatitis B.
Clin Gastroenterol Hepatol
; 21(6): 1513-1522.e4, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35863683
16.
Off-Therapy Response After Nucleos(t)ide Analogue Withdrawal in Patients With Chronic Hepatitis B: An International, Multicenter, Multiethnic Cohort (RETRACT-B Study).
Gastroenterology
; 162(3): 757-771.e4, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34762906
17.
Imprint of unconventional T-cell response in acute hepatitis C persists despite successful early antiviral treatment.
Eur J Immunol
; 52(3): 472-483, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34843107
18.
Incidence of Hepatic Decompensation After Nucleos(t)ide Analog Withdrawal: Results From a Large, International, Multiethnic Cohort of Patients With Chronic Hepatitis B (RETRACT-B Study).
Am J Gastroenterol
; 118(9): 1601-1608, 2023 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36719174
19.
Kinetics and predictive value of HBcrAg, HBV RNA and anti-HBc during bulevirtide treatment of chronic HDV-infected patients.
J Viral Hepat
; 30(4): 283-286, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36648369
20.
Bile acid increase during bulevirtide treatment of hepatitis D is not associated with a decline in HDV RNA.
J Viral Hepat
; 30(7): 597-606, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36924318